Ligand profile
66V
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00143 — Alpha-xylosidase
Identifiers
Database identifiers and provenance.
- Ligand ID
66V- PDB
5i23- UniProt (similar protein)
B3PEE6- Target protein
- KP13_00143
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 163.5
- −1 ≤ LogP ≤ 5 -1.10
- MW ≤ 500 Da 347.4
- LogP ≤ 5 -1.10
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 163.5
Matches PAINS filter: azo_A(324). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
C(CCCCN=[N+]=N)CCCN[C@H]1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1O)O)O)O)COC(CCCCN=[N+]=N)CCCN[C@H]1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1O)O)O)O)CO
InChI=1S/C15H31N4O5/c16-19-18-8-6-4-2-1-3-5-7-17-11-10(9-20)12(21)14(23)15(24)13(11)22/h10-17,20-24H,1-9H2/q+1/t10-,11-,12+,13+,14-,15-/m0/s1InChI=1S/C15H31N4O5/c16-19-18-8-6-4-2-1-3-5-7-17-11-10(9-20)12(21)14(23)15(24)13(11)22/h10-17,20-24H,1-9H2/q+1/t10-,11-,12+,13+,14-,15-/m0/s1
KPTZFIOZQLVZBJ-SAAWNECCSA-NKPTZFIOZQLVZBJ-SAAWNECCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01055
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 66V →
- PDB RCSB structure 5i23 →
- UniProt UniProt B3PEE6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “66V”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00143.
PDB 9
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).